IN2014MN00955A - - Google Patents
Info
- Publication number
- IN2014MN00955A IN2014MN00955A IN955MUN2014A IN2014MN00955A IN 2014MN00955 A IN2014MN00955 A IN 2014MN00955A IN 955MUN2014 A IN955MUN2014 A IN 955MUN2014A IN 2014MN00955 A IN2014MN00955 A IN 2014MN00955A
- Authority
- IN
- India
- Prior art keywords
- immunomodulator
- therapy
- ultrasound
- embolisation
- cyberknife
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Radiology & Medical Imaging (AREA)
- Communicable Diseases (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1120779.2A GB201120779D0 (en) | 2011-12-02 | 2011-12-02 | Cancer therapy |
| PCT/GB2012/052992 WO2013079980A1 (en) | 2011-12-02 | 2012-12-03 | Immunogenic treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN00955A true IN2014MN00955A (pl) | 2015-04-24 |
Family
ID=45509083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN955MUN2014 IN2014MN00955A (pl) | 2011-12-02 | 2012-12-03 |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20140356397A1 (pl) |
| EP (1) | EP2785361B1 (pl) |
| JP (1) | JP6085611B2 (pl) |
| KR (1) | KR20140097419A (pl) |
| CN (1) | CN104023733A (pl) |
| AU (1) | AU2012343536B2 (pl) |
| BR (1) | BR112014012880A2 (pl) |
| CA (1) | CA2857429A1 (pl) |
| GB (1) | GB201120779D0 (pl) |
| IL (1) | IL232890A0 (pl) |
| IN (1) | IN2014MN00955A (pl) |
| MX (1) | MX2014006511A (pl) |
| RU (1) | RU2014121335A (pl) |
| SG (1) | SG11201402396XA (pl) |
| WO (1) | WO2013079980A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11963716B2 (en) | 2010-07-19 | 2024-04-23 | Emblation Limited | Apparatus and method for the treatment of dermatological diseases or conditions |
| GB201120779D0 (en) * | 2011-12-02 | 2012-01-11 | Immodulon Therapeutics Ltd | Cancer therapy |
| GB201308325D0 (en) * | 2013-05-09 | 2013-06-19 | Immodulon Therapeutics Ltd | Cancer Therapy |
| EP3077041A4 (en) * | 2013-12-05 | 2017-08-23 | Rfemb Holdings LLC | Cancer immunotherapy by radiofrequency electrical membrane breakdown (rf-emb) |
| GB201322725D0 (en) * | 2013-12-20 | 2014-02-05 | Immodulon Therapeutics Ltd | Cancer therapy |
| CA2975123A1 (en) * | 2015-01-30 | 2016-08-04 | Rfemb Holdings, Llc | Radio frequency electrical membrane breakdown for the treatment of high risk and recurrent prostate cancer, unresectable pancreatic cancer, tumors of the breast, melanoma or other skin malignancies, sarcoma, soft tissue tumors, ductal carcinoma, neoplasia, and intra and extra luminal abnormal tissue |
| AU2016281765B2 (en) * | 2015-06-24 | 2022-06-16 | Immodulon Therapeutics Limited | A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy |
| RU2596505C1 (ru) * | 2015-07-02 | 2016-09-10 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России) | Способ лечения онкологических больных цитотоксическими лимфоцитами |
| US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
| CA3011460A1 (en) | 2016-01-15 | 2017-07-20 | Rfemb Holdings, Llc | Immunologic treatment of cancer |
| JP7175437B2 (ja) * | 2016-04-14 | 2022-11-21 | フェルドリヒ・カロ・ルイズ・アーべー | 放射線治療に用いる装置 |
| SG11201909107YA (en) | 2017-03-28 | 2019-11-28 | Emblation Ltd | Stenosis treatment |
| WO2019018813A1 (en) | 2017-07-21 | 2019-01-24 | Varian Medical Systems, Inc. | METHODS OF USING ULTRA HIGH DOSE RATE RADIATION AND THERAPEUTIC AGENTS |
| RU2664597C1 (ru) * | 2017-12-12 | 2018-08-21 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) | Способ комбинированного лечения больных первично операбельным и местно-распространенным неоперабельным раком молочной железы |
| CA3119915A1 (en) | 2018-12-03 | 2020-06-11 | Eric Steven BURAK | Radioimmunoconjugates and dna damage and repair inhibitor combination therapy |
| CA3162969A1 (en) * | 2019-12-27 | 2021-07-01 | Kunihiko Kobayashi | Cancer treatment method and medicine |
| EP4376945A1 (en) * | 2021-07-27 | 2024-06-05 | Immodulon Therapeutics Limited | A mycobacterium for use in cancer therapy |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5207223A (en) | 1990-10-19 | 1993-05-04 | Accuray, Inc. | Apparatus for and method of performing stereotaxic surgery |
| DE69126668T2 (de) * | 1990-11-08 | 1997-10-23 | Univ London | Mycobacterium als adjuvans für antigene |
| US5458125A (en) | 1994-01-28 | 1995-10-17 | Board Of Directors Of The Leland Standford Jr. University | Treatment planning method and apparatus for radiosurgery and radiation therapy |
| CA2369542C (en) | 1999-04-23 | 2009-10-27 | Qlt Inc. | Immuno-adjuvant pdt treatment of metastatic tumors |
| US20020022032A1 (en) | 1999-04-23 | 2002-02-21 | Curry Patrick Mark | Immuno-adjuvant PDT treatment of metastatic tumors |
| AU2002353366A1 (en) * | 2001-12-10 | 2003-06-23 | Bakulesh Mafatlal Khamar | The process of manufacturing a pharmaceutical composition useful for management of cancer |
| SI2206517T1 (sl) | 2002-07-03 | 2023-12-29 | Ono Pharmaceutical Co., Ltd. | Imunopotencirni sestavki,ki obsegajo protitelesa proti PD-L1 |
| CA2492160A1 (en) | 2002-07-12 | 2004-01-22 | The Johns Hopkins University | Mesothelin vaccines and model systems |
| EP1937303A4 (en) | 2005-10-21 | 2009-11-18 | Med College Georgia Res Inst | INTRODUCTION OF AN INDOLEAMINE-2,3-DIOXYGENASE IN DENDRITIC CELLS BY TLR LIGANDS AND APPLICATIONS THEREOF |
| US20080318252A1 (en) | 2007-04-23 | 2008-12-25 | Scott Kachlany | Rapid assay to test anti-cancer drugs under physiological conditions |
| GB0526033D0 (en) * | 2005-12-21 | 2006-02-01 | Bioeos Ltd | Method |
| EP2010216A4 (en) * | 2006-03-24 | 2010-06-09 | Donald L Morton | MYCOBACTERIAL IMMUNOTHERAPY FOR CANCER TREATMENT |
| WO2008110491A2 (en) | 2007-03-09 | 2008-09-18 | University Of Basel | Chemotherapy of neoplastic diseases using combinations of rapamycin and compounds modulating mtor pathway alone or in combination with heat |
| PL2170959T3 (pl) | 2007-06-18 | 2014-03-31 | Merck Sharp & Dohme | Przeciwciała przeciwko ludzkiemu receptorowi programowanej śmierci PD-1 |
| RS53782B1 (en) * | 2008-10-01 | 2015-06-30 | Immatics Biotechnologies Gmbh | TUMOR-ASSOCIATED PEPTIDES PREPARED AND ANTI-CHANGE RESPONSE FOR GLIOBLASTOMA (GBM) AND OTHER CANCER TREATMENTS |
| US8367075B2 (en) | 2010-07-02 | 2013-02-05 | Indian Institute Of Science | Synergistic combination and method thereof |
| US9114158B2 (en) * | 2011-03-09 | 2015-08-25 | The Johns Hopkins University | Compounds and methods of use in ablative radiotherapy |
| EP2723381A4 (en) | 2011-06-21 | 2015-03-18 | Univ Johns Hopkins | FOCUSED RADIATION FOR THE REINFORCEMENT OF IMMUNE TREATMENTS AGAINST NEOPLASMS |
| GB201120779D0 (en) * | 2011-12-02 | 2012-01-11 | Immodulon Therapeutics Ltd | Cancer therapy |
| EP2620159A1 (en) | 2012-01-24 | 2013-07-31 | Institut Pasteur | Improved cancer treatment by immunotherapy with bcg or antigenically related non-pathogenic mycobacteria |
| WO2013114367A2 (en) | 2012-02-01 | 2013-08-08 | Compugen Ltd. | C10rf32 antibodies, and uses thereof for treatment of cancer |
| US8617520B2 (en) | 2012-02-15 | 2013-12-31 | Immodulon Therapeutics Limited | Cancer therapy |
| GB201308325D0 (en) | 2013-05-09 | 2013-06-19 | Immodulon Therapeutics Ltd | Cancer Therapy |
| GB201322725D0 (en) | 2013-12-20 | 2014-02-05 | Immodulon Therapeutics Ltd | Cancer therapy |
| EP4070818A3 (en) | 2014-01-06 | 2023-01-11 | The Trustees of the University of Pennsylvania | Pd1 and pdl1 antibodies and vaccine combinations and use of same for immunotherapy |
| US10975112B2 (en) | 2015-06-16 | 2021-04-13 | Hangzhou Dac Biotech Co., Ltd. | Linkers for conjugation of cell-binding molecules |
| AU2016281765B2 (en) | 2015-06-24 | 2022-06-16 | Immodulon Therapeutics Limited | A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy |
| JP2021529741A (ja) | 2018-06-25 | 2021-11-04 | イモデュロン セラピューティクス リミテッド | がん治療 |
-
2011
- 2011-12-02 GB GBGB1120779.2A patent/GB201120779D0/en not_active Ceased
-
2012
- 2012-12-03 EP EP12799260.0A patent/EP2785361B1/en active Active
- 2012-12-03 MX MX2014006511A patent/MX2014006511A/es unknown
- 2012-12-03 JP JP2014543984A patent/JP6085611B2/ja active Active
- 2012-12-03 RU RU2014121335A patent/RU2014121335A/ru unknown
- 2012-12-03 CN CN201280059421.0A patent/CN104023733A/zh active Pending
- 2012-12-03 KR KR1020147016935A patent/KR20140097419A/ko not_active Application Discontinuation
- 2012-12-03 BR BR112014012880A patent/BR112014012880A2/pt not_active IP Right Cessation
- 2012-12-03 US US14/361,992 patent/US20140356397A1/en not_active Abandoned
- 2012-12-03 WO PCT/GB2012/052992 patent/WO2013079980A1/en active Application Filing
- 2012-12-03 CA CA2857429A patent/CA2857429A1/en not_active Abandoned
- 2012-12-03 SG SG11201402396XA patent/SG11201402396XA/en unknown
- 2012-12-03 AU AU2012343536A patent/AU2012343536B2/en active Active
- 2012-12-03 IN IN955MUN2014 patent/IN2014MN00955A/en unknown
-
2014
- 2014-05-29 IL IL232890A patent/IL232890A0/en unknown
-
2018
- 2018-12-19 US US16/225,028 patent/US11318193B2/en active Active
-
2020
- 2020-06-30 US US16/916,194 patent/US11554166B2/en active Active
-
2023
- 2023-01-13 US US18/154,177 patent/US20230149525A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB201120779D0 (en) | 2012-01-11 |
| IL232890A0 (en) | 2014-07-31 |
| US20230149525A1 (en) | 2023-05-18 |
| WO2013079980A1 (en) | 2013-06-06 |
| EP2785361A1 (en) | 2014-10-08 |
| JP2014533743A (ja) | 2014-12-15 |
| AU2012343536B2 (en) | 2017-08-24 |
| SG11201402396XA (en) | 2014-10-30 |
| CA2857429A1 (en) | 2013-06-06 |
| US11318193B2 (en) | 2022-05-03 |
| JP6085611B2 (ja) | 2017-02-22 |
| BR112014012880A2 (pt) | 2017-06-13 |
| US20140356397A1 (en) | 2014-12-04 |
| KR20140097419A (ko) | 2014-08-06 |
| EP2785361B1 (en) | 2018-11-28 |
| US11554166B2 (en) | 2023-01-17 |
| RU2014121335A (ru) | 2016-01-27 |
| NZ624994A (en) | 2016-10-28 |
| US20200338181A1 (en) | 2020-10-29 |
| MX2014006511A (es) | 2014-12-05 |
| AU2012343536A1 (en) | 2014-06-05 |
| US20190224294A1 (en) | 2019-07-25 |
| CN104023733A (zh) | 2014-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN00955A (pl) | ||
| WO2011137449A3 (en) | Method and apparatus for treatment of ocular tissue using combined modalities | |
| MX2019007095A (es) | Dispositivos y el uso de los mismos en metodos para terapia de ablacion. | |
| Mellal et al. | Thermal therapy modalities for cancer treatment: A review and future perspectives | |
| WO2015008154A3 (en) | Self-administrable method, system, and apparatus for non-invasive neurostimulation therapy of the brain | |
| WO2007067830A3 (en) | Radiation ablation tracking system | |
| US20240123253A1 (en) | Photodynamic therapy devices, systems and methods | |
| Ross et al. | Laser-tissue interactions | |
| Yin et al. | Characteristic analysis of light and heat transfer in photothermal therapy using multiple-light-source heating strategy | |
| CN103638606B (zh) | 光热和光动力治疗装置 | |
| Yu et al. | 18 years long-term results of facial port-wine stain (PWS) after photodynamic therapy (PDT)–A case report | |
| CN203663257U (zh) | 光热和光动力治疗装置 | |
| WO2013166504A3 (en) | Targeted delivery of active agents using thermally stimulated large increase of perfusion by high intensity focused ultrasound | |
| Yanase et al. | Hyperthermia enhances the antitumor effect of photodynamic therapy with ALA hexyl ester in a squamous cell carcinoma tumor model | |
| Yoo et al. | Non-ablative fractional thulium laser irradiation suppresses early tumor growth | |
| RU2006101260A (ru) | Способ фотодинамической терапии онкологических заболеваний | |
| RU2010129236A (ru) | Способ лечения местнораспространенных онкологических заболеваний в эксперименте | |
| Liu et al. | Biophotonics in photomedicine | |
| Soni | Heat transfer phenomenon and optical interaction during nanoparticle assisted thermal therapy | |
| PH12015502086A1 (en) | Ablative immunotherapy | |
| Karimian et al. | Review the effect of hyperthermia using iron and magnetic nanoparticles in cancer treatment in chemical injuries | |
| Soni et al. | Spatiotemporal Temperature in a Tumor During Nanorod Assisted Thermal Therapy | |
| Moretti et al. | Conventional and unconventional use of lasers in skin disorders | |
| Ioritani | Contact Laser Vaporization of Prostate (CVP) using 980 nm High Power Diode Laser and End-Firing TwisterTM Large Fiber | |
| Lee et al. | Use of a 595-nm pulsed-dye laser to treat post-procedure ecchymoses |